nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

12.09.2017 | editorial

An Austrian view of the 2017 consensus for the treatment of early breast cancer

verfasst von: Guenther G. Steger, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Excerpt

As the recently appointed Chair for Medical Breast Cancer Research at the Medical University of Vienna which is the first of its kind in the German-speaking world and which was established by the university due to the ever growing importance of breast cancer oncology, I was invited to write this editorial for MEMO’s series on breast cancer appearing in this issue of the journal. …

Vorheriger Artikel Development of chemotherapeutics in oncology: is there anything new?

Nächster Artikel What’s new in chemotherapy for non-small cell lung cancer?

Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn H‑J, Thürlimann B, Panel Members of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2017;28(8):1700–12.PubMed

Pfeiler G, Bartsch R, Fitzal F. Highlights from the 2017 St. Gallen Breast Cancer Consensus. Memo. 2017;10. https://doi.org/10.1007/s12254-017-0349-x.

Exner R. Local therapies for breast cancer. Memo. 2017;10. https://doi.org/10.1007/s12254-017-0336-2.

Baltzer PAT, Kapetas P, Marino MA, Clauser P. New diagnostic tools for breast cancer. Memo. 2017;10. https://doi.org/10.1007/s12254-017-0341-5.

Titel: An Austrian view of the 2017 consensus for the treatment of early breast cancer
verfasst von: Guenther G. Steger, MD
Publikationsdatum: 12.09.2017
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 3/2017
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-017-0356-y

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

What’s new in chemotherapy for non-small cell lung cancer?

New chemotherapies in gastric adenocarcinoma

Development of chemotherapeutics in oncology: is there anything new?

Highlights from the 2017 St. Gallen Breast Cancer Consensus

Disease control with brentuximab vedotin in an aged patient with primary cutaneous anaplastic large-cell lymphoma

Novel therapeutics in supportive cancer treatment